Promoting Cervical Cancer Screening for Emergency Department Patients

Not Applicable

Completed

• Conditions: Cervical Cancer

• Registration Number: NCT03483610
• Lead Sponsor: University of Rochester

Brief Summary

The purpose of this study is to learn methods to encourage women to get recommended cervical cancer screening. Cervical cancer screening is an important part of cervical cancer prevention. The study team will determine if the patient is currently up-to-date with cervical cancer screening recommendations. If the patient is not up-to-date, then they will be randomly assigned to one of two interventions. One intervention consists only of referral to a women's health care provider to obtain cervical cancer screening. The other intervention consists of receiving a total of 3 text messages at 30-day intervals encouraging follow-up for cervical cancer screening.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2018-03-23
• Study First Submitted QC: 2018-03-23
• Study First Posted: 2018-03-30
• Study Start: 2018-06-25
• Primary Completion: 2019-05-31
• Study Completion: 2019-05-31
• Results First Submitted: 2024-09-24
• Status Verified: 2025-01
• Results First Submitted QC: 2025-01-22
• Last Update Submitted: 2025-01-22
• Results First Posted: 2025-01-24
• Last Update Posted: 2025-01-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 95

Inclusion Criteria

• Registered patient in the Emergency Department of the University of Rochester Medical Center
• Women
• Age 21 - 65

Exclusion Criteria

• Past hysterectomy with cervical removal
• Known infection with HIV (screening recommendations for women with HIV differ from the general population)
• Non-English speaking
• Inability to consent
• Lack of text-capable mobile phone and/or inability to use text function

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Number of Participants Who Scheduled or Completed Cervical Cancer Screening	150 days

Trial Locations

Locations (1)

University of Rochester, Department of Emergency Medicine; 🇺🇸 Rochester, New York, United States